Barclays Starts Menlo Therapeutics (MNLO) at Overweight
Tweet
Share
E-mailGet Alerts MNLO Hot Sheet
Price: $1.35 --0%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Join SI Premium – FREE
Barclays analyst Balaji Prasad initiates coverage on Menlo Therapeutics (NASDAQ: MNLO) with a Overweight rating and a price target of $8.00.
For an analyst ratings summary and ratings history on Menlo Therapeutics click here. For more ratings news on Menlo Therapeutics click here.
Shares of Menlo Therapeutics closed at $3.06 yesterday.
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- H.C. Wainwright Assumes Alpha Compute Corp. (ALP) at Neutral
- Piper Sandler Starts Dave Inc (DAVE) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
